Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coffey

Showing results (481-490 of 512) with videos related to

Pageof 52
Sort By:
Annals of Clinical and Translational Neurology|December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohortKenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional StudyTanya Simuni, Michael C Brumm, Liz Uribe, et al.
Neurology|February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseKatheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Acta Neuropathologica Communications|February 15, 2022
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligenceMaxim Signaevsky, Bahram Marami, Marcel Prastawa, et al.
Acta Neuropathologica|March 30, 2016
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative studyJu-Hee Kang, Brit Mollenhauer, Christopher S Coffey, et al.
Applied Biosafety : Journal of the American Biological Safety Association|April 6, 2023
Establishing a Health Information Technology for the Vaccination of National Institutes of Health StaffJon Walter McKeeby, Christopher M Siwy, Jordan Southers, et al.
Neurology|August 7, 2024
Long-Term Dementia Risk in Parkinson DiseaseJulia Gallagher, Caroline Gochanour, Chelsea Caspell-Garcia, et al.
Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Journal of Neuromuscular Diseases|September 19, 2018
Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker StudyKristin J Krosschell, Michael Bosch, Leslie Nelson, et al.
Neurology Open Access|July 8, 2025
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH TrialKa-Ho Wong, Gregory Scott Day, James C Torner, et al.
Pageof 52

Showing results (481-490 of 512) with videos related to

Sort By:
Pageof 52
Annals of Clinical and Translational Neurology|December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohortKenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 20, 2020
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional StudyTanya Simuni, Michael C Brumm, Liz Uribe, et al.
Neurology|February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseKatheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Acta Neuropathologica Communications|February 15, 2022
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligenceMaxim Signaevsky, Bahram Marami, Marcel Prastawa, et al.
Acta Neuropathologica|March 30, 2016
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative studyJu-Hee Kang, Brit Mollenhauer, Christopher S Coffey, et al.
Applied Biosafety : Journal of the American Biological Safety Association|April 6, 2023
Establishing a Health Information Technology for the Vaccination of National Institutes of Health StaffJon Walter McKeeby, Christopher M Siwy, Jordan Southers, et al.
Neurology|August 7, 2024
Long-Term Dementia Risk in Parkinson DiseaseJulia Gallagher, Caroline Gochanour, Chelsea Caspell-Garcia, et al.
Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Journal of Neuromuscular Diseases|September 19, 2018
Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker StudyKristin J Krosschell, Michael Bosch, Leslie Nelson, et al.
Neurology Open Access|July 8, 2025
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH TrialKa-Ho Wong, Gregory Scott Day, James C Torner, et al.
Pageof 52